These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17324828)

  • 21. Ice minimizes discomfort associated with injection of botulinum toxin type A for the treatment of palmar and plantar hyperhidrosis.
    Smith KC; Comite SL; Storwick GS
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S88-91. PubMed ID: 17241420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin: a treatment for compensatory hyperhidrosis in the trunk.
    Kim WO; Kil HK; Yoon KB; Noh KU
    Dermatol Surg; 2009 May; 35(5):833-8; discussion 838. PubMed ID: 19389096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].
    Kreyden OP; Burg G
    Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1084-90. PubMed ID: 10971942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.
    Flanagan KH; King R; Glaser DA
    J Drugs Dermatol; 2008 Mar; 7(3):221-7. PubMed ID: 18380203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
    Schnider P; Binder M; Auff E; Kittler H; Berger T; Wolff K
    Br J Dermatol; 1997 Apr; 136(4):548-52. PubMed ID: 9155956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
    Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
    Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosocial aspects of patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression and increased quality of life after treatment with botulinum toxin A.
    Weber A; Heger S; Sinkgraven R; Heckmann M; Elsner P; Rzany B
    Br J Dermatol; 2005 Feb; 152(2):342-5. PubMed ID: 15727649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The place of botulinum toxin type A in the treatment of focal hyperhidrosis.
    Lowe N; Campanati A; Bodokh I; Cliff S; Jaen P; Kreyden O; Naumann M; Offidani A; Vadoud J; Hamm H
    Br J Dermatol; 2004 Dec; 151(6):1115-22. PubMed ID: 15606505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements.
    Campanati A; Lagalla G; Penna L; Gesuita R; Offidani A
    J Am Acad Dermatol; 2004 Sep; 51(3):345-8. PubMed ID: 15337974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical botulinum toxin to treat hyperhidrosis? No sweat!
    Lim EC; Seet RC; Chow A; Oh VM; Ong BK; Wilder-Smith EP
    Med Hypotheses; 2006; 67(1):27-32. PubMed ID: 16524669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of palmar hyperhidrosis with botulinum toxin type A: 44 months of experience.
    Pérez-Bernal AM; Avalos-Peralta P; Moreno-Ramírez D; Camacho F
    J Cosmet Dermatol; 2005 Sep; 4(3):163-6. PubMed ID: 17129260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Focal hyperhidrosis: disease characteristics and treatments].
    Campanelli A; Salomon D
    Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of quality of life in patients with primary axillary hyperhidrosis before and after suction-curettage.
    Bechara FG; Gambichler T; Bader A; Sand M; Altmeyer P; Hoffmann K
    J Am Acad Dermatol; 2007 Aug; 57(2):207-12. PubMed ID: 17368632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrophy of the intrinsic musculature of the hands associated with the use of botulinum toxin-A injections for hyperhidrosis: a case report and review of the literature.
    Glass GE; Hussain M; Fleming AN; Powell BW
    J Plast Reconstr Aesthet Surg; 2009 Aug; 62(8):e274-6. PubMed ID: 18203669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.